Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
26,892,330
-
Shares change
-
-1,924,350
-
Total reported value, excl. options
-
$1,220,577,828
-
Value change
-
-$88,233,808
-
Put/Call ratio
-
4.37%
-
Number of buys
-
60
-
Number of sells
-
-93
-
Price
-
$45.19
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q1 2016
188 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q1 2016.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,892,330 shares
of 834,731,296 outstanding shares and own 3.22% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (4,775,345 shares), AQR CAPITAL MANAGEMENT LLC (3,231,118 shares), Commonwealth Bank of Australia (3,086,172 shares), ROYAL BANK OF CANADA (1,855,073 shares), BlackRock Group LTD (1,370,889 shares), VANGUARD GROUP INC (1,309,495 shares), VONTOBEL ASSET MANAGEMENT INC (1,247,106 shares), DIMENSIONAL FUND ADVISORS LP (690,694 shares), CREDIT SUISSE AG/ (552,691 shares), and STATE STREET CORP (500,478 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.